This resolution expresses support for women nationwide to have access to comprehensive, convenient, compassionate, life-affirming, and high-quality health care.
This bill blocks federal funding for colleges that operate or partner with campus health clinics providing abortion drugs or abortions to students or staff. It requires institutions receiving federal funds to annually certify that no such services are offered at their on-campus clinics. The law specifically excludes hospital-based clinics from coverage and defines "abortion drugs" as medications intended to terminate pregnancy (excluding specific medical exceptions). It directly affects public and private colleges receiving federal aid, as most institutions of higher education qualify for such funding.
Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.
Leaker Accountability Act of 2023 This bill establishes a new federal crime for the unauthorized disclosure of confidential information by officers or employees of the Supreme Court. Specifically, the bill prohibits an officer or employee of the Supreme Court from knowingly publishing, divulging, disclosing, or making known in any manner or to any extent not authorized by law any confidential information coming to that officer or employee in the course of the employment or official duties of that officer or employee. A violation is subject to criminal penalties—a fine, a prison term of up to five years, or both.
Teleabortion Prevention Act of 2023 This bill restricts the use of telehealth for chemical abortions (also known as medication abortions). Specifically, it requires a provider who dispenses or prescribes medication for a chemical abortion to physically examine the patient, be physically present at the location of the chemical abortion, and schedule a follow-up visit for the patient. The bill provides an exception for a chemical abortion that is necessary to save the life of a mother whose life is endangered by a physical disorder, illness, injury, or condition. The bill establishes criminal penalties—a fine, a prison term of up to two years, or both—for a provider who does not comply with the requirements. A patient who undergoes a chemical abortion may not be prosecuted.
History and Tradition Protection Act of 2023 This bill limits the types of relief that may be awarded in civil suits that involve violations of the Constitution's Establishment Clause, which prohibits the government from establishing a religion. Current law provides a statutory civil cause of action against state and local government actors for violations of constitutional rights, also known as Section 1983 lawsuits. The bill limits relief for Section 1983 lawsuits that involve violations of the Establishment Clause to injunctive and declaratory relief (i.e., nonmonetary relief) and prohibits the award of attorneys' fees in these cases, including those that involve monuments, public buildings, official seals, and government proceedings. The bill applies the same restrictions to similar lawsuits against federal agencies.
Standardizing Thresholds Of Penalties for Fentanyl Act or the STOP Fentanyl Act This bill reduces the drug quantity thresholds that trigger a mandatory minimum prison term for a defendant who manufactures, distributes, imports, exports, or possesses with intent to distribute fentanyl. The bill also creates enhanced criminal penalties for certain violations involving fentanyl that was imported along the U.S.-Mexico border. Specifically, the bill reduces from 400 to 5 grams the fentanyl quantity and from 100 to 0.05 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for high-level first-time or repeat offenders. It also reduces from 40 to 0.5 grams the fentanyl quantity and from 10 to 0.005 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for low-level first-time or repeat offenders. Additionally, the bill creates enhanced mandatory minimum prison terms for importing or exporting fentanyl that was imported along the U.S.-Mexico border.
HR 330, the Title X Abortion Provider Prohibition Act, prohibits federal funding under the Title X family planning program for clinics that perform or fund abortions, except in cases of rape, incest, or when a physician certifies a life-threatening condition. It requires clinics receiving Title X funds to certify they do not provide or fund abortions (with the specified exceptions), and hospitals are exempt if they don't fund non-hospital abortion providers. The bill mandates annual reports to Congress listing all funded clinics, the number of abortions performed under exceptions (including rape/incest cases), and the certification dates for each clinic. This directly affects Title X-funded clinics nationwide that provide abortion services or fund such services, altering their eligibility for federal funding. The law aims to restrict federal support for abortion access within the Title X program while maintaining limited exceptions.
HR 279, the Pharmacist Conscience Protection Act, protects pharmacists, pharmacy technicians, and pharmacy owners who refuse to dispense medications approved for abortion or that they believe may be used for abortion, based on moral, religious, or medical objections. The bill prohibits federal agencies and entities receiving federal funds (including state/local governments) from discriminating against, penalizing, or retaliating against these providers for such refusals. It does not require pharmacists to dispense these medications and explicitly preserves stronger state conscience protections. This law directly affects pharmacists and pharmacies seeking to align their practice with personal or religious beliefs regarding abortion-related medications.
Triple-Negative Breast Cancer Research and Education Act of 2023 This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors. Specifically, the National Institutes of Health must conduct and support research into the disease. Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.
This bill requires family planning services funded under Title V of the Social Security Act to provide pamphlets containing regional adoption center contact information to patients during consultations about medical or abortion services. The pamphlets must include a comprehensive list of adoption centers in the region, along with each center's address and phone number. It mandates that services offer patients the opportunity to read these pamphlets at the time of inquiry. The provision uses existing Title V funding and does not create new financial obligations.
HR 128, the Defund Planned Parenthood Act of 2023, blocks federal funding to Planned Parenthood Federation of America and its affiliates for one year unless they certify they will not perform or fund abortions (except in cases of rape, incest, or life-threatening conditions for the patient). This directly affects Planned Parenthood clinics and their federal funding streams. The bill redirects $235 million to community health centers under the Public Health Service Act to continue providing women’s health services like contraception, cancer screenings, and prenatal care. It requires repayment of funds if Planned Parenthood violates the certification and explicitly states the law won’t reduce overall federal funding for women’s health services.